Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Santhera Pharmaceuticals Holding | Switzerland | Healthcare | Pharmaceuticals | 97.6% | CHF 200.27M | 2.7x | 0.02 | CHF 15.90 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Private Equity Holding AG | Switzerland | Financials | Investment Banking & Investment Services | 7.5% | CHF 184.09M | 27.5x | 0.11 | CHF 74.60 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | 3.8% | CHF 2.08B | 16.9x | 0.12 | CHF 38.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | 2.2% | CHF 2.09B | 16.6x | 0.12 | CHF 38.15 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.3% Upside | Upgrade to Pro+ | |
Alpine Select AG | Switzerland | Financials | Investment Banking & Investment Services | 2% | CHF 65.32M | 22.3x | 0.13 | CHF 7.50 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSMO Pharma | Switzerland | Healthcare | Pharmaceuticals | 1.1% | CHF 1.03B | 15.7x | 0.03 | CHF 64 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.1% Upside | Upgrade to Pro+ | |
HBM Healthcare Investments | Switzerland | Financials | Investment Banking & Investment Services | 0.7% | CHF 1.29B | 5.9x | 0.02 | CHF 191.80 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alpine Select | Switzerland | Financials | Investment Banking & Investment Services | 0% | CHF 66.20M | 22.4x | 0.13 | CHF 7.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HBM Healthcare Investments | Switzerland | Financials | Investment Banking & Investment Services | -0.5% | CHF 1.29B | 5.9x | 0.02 | CHF 191.20 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.3% Upside | Upgrade to Pro+ | |
Kuros Biosciences | Switzerland | Healthcare | Biotechnology & Medical Research | -9.4% | CHF 855.23M | -73.8x | -3.07 | CHF 22.55 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eeii AG | Switzerland | Financials | Investment Holding Companies | -51.6% | CHF 2.29M | -10.1x | -0.13 | CHF 1.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |